How should Ménière’s disease be managed?

Management of Ménière's Disease

Begin with dietary sodium restriction (1500-2300 mg daily), lifestyle modifications, and patient education; escalate through vestibular suppressants for acute attacks, intratympanic steroids for refractory disease, then intratympanic gentamicin, and finally surgical ablation for severe cases unresponsive to all other therapies. 1, 2

Initial Conservative Management

Dietary and Lifestyle Modifications

• Restrict sodium intake to 1500-2300 mg daily as the foundational intervention for all patients, with greatest benefit in those achieving lowest urinary sodium excretion 2
• Limit caffeine consumption, as higher intake correlates with increased symptom severity 2
• Restrict alcohol intake 1, 2
• Identify and avoid individual triggers (stress, allergies, barometric pressure changes, specific foods) through systematic symptom journaling 1, 2
• Consider dietitian counseling to optimize adherence and outcomes 2

Patient Education (Essential Component)

• Educate all patients about natural history, symptom control measures, treatment options, and outcomes at diagnosis 1
• Provide both verbal and written materials at appropriate literacy levels 1
• Discuss that vertigo attacks are sporadic and unpredictable, hearing may fluctuate or stabilize over time, and disease typically stabilizes around 8 years after onset (though highly variable) 1
• Inform patients that bilateral involvement can occur, which is critical before considering ablative procedures 1
• Allow sufficient time for questions to facilitate shared decision-making 1

Acute Vertigo Attack Management

Symptomatic Treatment During Attacks

• Offer a limited course of vestibular suppressants (e.g., meclizine) only during acute vertigo episodes, not for continuous prophylaxis 1, 2
• Prescribe antiemetics to control nausea during acute attacks 2
• Use benzodiazepines with extreme caution due to significant dependence risk 1, 2
• Anticholinergics (scopolamine, atropine) may suppress attacks but cause limiting side effects (blurred vision, dry mouth, urinary retention, sedation) 2

Critical Pitfall: Never prescribe vestibular suppressants for continuous use—they are strictly for acute attack management only 1, 2

Oral Pharmacotherapy for Symptom Reduction

Systemic Medications (Second-Line)

• Consider diuretics to reduce excess body fluid, though evidence certainty is very low 2
• Betahistine (histamine analogue promoting inner-ear vasodilation) may be used, but efficacy evidence remains very low-certainty 1, 2, 3
• Prescribe antihistamines for patients with concurrent allergic rhinitis (present in up to 30% of cases) 2

Intratympanic Therapy for Active Disease

First-Line Invasive Option

• Offer intratympanic corticosteroids to patients with active disease failing conservative measures—this is hearing-preserving and appropriate for refractory symptoms 1, 2
• No standardized dosing protocol exists; titration is individualized 2

Second-Line Invasive Option

• Offer intratympanic gentamicin to patients unresponsive to non-ablative therapy—this provides the most effective long-term vertigo control but carries permanent hearing loss risk 1, 2, 4
• This is a partially ablative procedure reserved for treatment failures 2, 5
• No consensus exists on optimal dosage or titration 2

Surgical Options for Severe Refractory Disease

Hearing-Sparing Ablative Surgery

• Vestibular nerve section is recommended for severe refractory cases when hearing preservation is desired 2, 4

Complete Ablative Surgery

• Labyrinthectomy provides complete vestibular ablation for patients with non-usable hearing 2, 4
• May be combined with cochlear implantation for auditory rehabilitation 2

Critical Consideration: Before ablative procedures, counsel patients about potential bilateral disease progression, which could leave them without meaningful hearing or vestibular function 1

Vestibular Rehabilitation

Physical Therapy Indications

• Offer vestibular rehabilitation/physical therapy to patients who have failed less definitive therapy, especially after ablative procedures 1, 2
• This improves long-term balance, reduces anxiety, and facilitates central compensation following labyrinthectomy 2
• Particularly important for patients with residual chronic imbalance 2

Adjunctive Management

Hearing and Migraine Management

• Recommend hearing aids for persistent hearing loss 2
• Consider migraine prophylaxis in recalcitrant cases where concurrent migraine symptoms contribute to disease burden 2, 5

Contraindicated Interventions

Do not prescribe positive-pressure therapy for chronic imbalance—this is specifically advised against 1, 2

Disease Staging and Treatment Algorithm

Mild Disease (Infrequent, Mild Vertigo; Minimal Hearing Loss)

• Conservative management with dietary and lifestyle modifications only 2

Moderate Disease (Occasional Moderate-Severe Attacks)

• Add oral medications (diuretics, betahistine) 2
• Consider intratympanic steroids if inadequate response 2

Severe Disease (Frequent Debilitating Episodes)

• Progress to intratympanic gentamicin 2
• Consider surgical interventions if gentamicin fails 2

Monitoring and Documentation

Required Follow-Up

• Document resolution, improvement, or worsening of vertigo, tinnitus, hearing loss, and quality of life changes at each visit 1, 2
• Obtain audiogram regularly to assess ongoing hearing function 1, 2

Evidence Strength Note: Most recommendations are supported by low-certainty evidence from small RCTs and observational studies, with the exception of guideline-level consensus statements from the American Academy of Otolaryngology-Head and Neck Surgery 1, 2